SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes
NCT07272057
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
SGLT-2 inhibitor
OTHER:
Sham (No Treatment)
Sponsor
Shanghai Chest Hospital